Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
International Journal of Medicinal Mushrooms
IF: 1.423 5-Year IF: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Print: 1521-9437
ISSN Online: 1940-4344

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2018026564
pages 657-664

Profiles of Little-Known Medicinal Polypores: Funalia trogii (Agaricomycetes)

Ivan V. Zmitrovich
Laboratory of Systematics and Geography of the Fungi of the Komarov Botanical Institute of the Russian Academy of Sciences, Prof. Popova St. 2, St. Petersburg, 197376, Russia
Margarita A. Bondartseva
Laboratory of Systematics and Geography of Fungi, Komarov Botanical Institute of the Russian Academy of Sciences, Saint Petersburg, Russia
Stanislav P. Arefyev
Institute of Problems of Development of the North – Subdivision of Federal Research Center Tyumen Scientific Center of Siberian Branch of the Russian Academy of Sciences, Tyumen, Russia
Oleg N. Ezhov
N. Laverov Federal Center for Integrated Arctic Research, Arkhangelsk, Russia
Solomon P. Wasser
N.G. Kholodny Institute of Botany, NAS of Ukraine, 2 Tereshchenkovskaya Str., Kiev 01004, Ukraine; International Center for Cryptogamic Plants and Fungi, Institute of Evolution, University of Haifa, Mount Carmel, Haifa, Israel

ABSTRACT

The purpose of this study was to comprehensively characterize little-known polypores that have recently been found to possess anticancer activity and thus can be used in targeted cancer therapy. Funalia trogii is a polypore with bipolar distribution and has been found by harvesters working in taiga forests, broadleaf forests, and forest-steppes of the Holarctic, and in semiarid temperate forests of the Southern Hemisphere. Substances such as gibberellic acid, abscisic acid, indole-3-acetic acid, and natural cytokinin were determined in culture media of F. trogii. Also, laccases and peroxidases of spare action have been reported in F. trogii culture media. All of the aforementioned substances can be used in targeted cancer therapy, but further investigation of F. trogii is recommended; more details of its health benefits could expand its use in mycotherapy.


Articles with similar content:

Profiles of Little-Known Medicinal Polypores: Haploporus odorus (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 8
Nina V. Belova, Margarita A. Bondartseva, Ivan V. Zmitrovich, Oleg N. Ezhov, Stanislav P. Arefyev, Sergey V. Volobuev, Viacheslav A. Vlasenko, Vladimir I. Kapitonov, Yulia R. Khimich, Ludmila G. Isaeva, Solomon P. Wasser
Profiles of Little-Known Medicinal Polypores: Earliella scabrosa (Agaricomycetes)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 11
Solomon P. Wasser, Ivan V. Zmitrovich, Oleg N. Ezhov, Kiran R. Ranadive
Novel Ganoderma lucidum-based beverage with antibacterial and antioxidant effects
International Journal of Medicinal Mushrooms, Vol.20, 2018, issue 3
Miomir Niksic
Cloning and Characterization of Polyphenoloxidase DNA from Agaricus brasiliensis S. Wasser et al. (Agaricomycetideae)
International Journal of Medicinal Mushrooms, Vol.8, 2006, issue 1
Akiko Matsumoto-Akanuma, Naohito Ohno, Akihiko Yamagishi, Masuro Motoi
Hepatoma Cell Growth Inhibition by Inducing Apoptosis with Polysaccharide Isolated from Turkey Tail Medicinal Mushroom, Trametes versicolor (L.: Fr.) Lloyd (Aphyllophoromycetideae)
International Journal of Medicinal Mushrooms, Vol.12, 2010, issue 3
Xinzhong Cai, Xin Zhou, Lifen Tian, Yan Pi, Shouyi Qiao, Juan Lin